Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery.

Mehring, Gisa; Steinbach, Christina; Pose, Randi; Knipper, Sophie; Koehler, Daniel; Werner, Stefan; Riethdorf, Sabine; von Amsberg, Gunhild; Ambrosini, Francesca; Maurer, Tobias

Mehring, Gisa; Steinbach, Christina; Pose, Randi; Knipper, Sophie; Koehler, Daniel; Werner, Stefan; Riethdorf, Sabine; von Amsberg, Gunhild; Ambrosini, Francesca; Maurer, Tobias.

Afiliación

Mehring G; Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Steinbach C; Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Pose R; Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Knipper S; Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Koehler D; Department of Urology, Vivantes Klinikum Am Urban, Berlin, Germany.
Werner S; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
von Amsberg G; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ambrosini F; Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Maurer T; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hubertus Wald Tumorzentrum - University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

World J Urol ; 42(1): 256, 2024 Apr 24.

Article en En | MEDLINE | ID: mdl-38656636

Asunto(s)

Fosfatasa Alcalina; Biomarcadores de Tumor; Antígeno Carcinoembrionario; L-Lactato Deshidrogenasa; Recurrencia Local de Neoplasia; Fosfopiruvato Hidratasa; Neoplasias de la Próstata; Anciano; Humanos; Masculino; Persona de Mediana Edad; Fosfatasa Alcalina/sangre; Antígenos de Superficie/sangre; Biomarcadores de Tumor/sangre; Antígeno Carcinoembrionario/sangre; Glutamato Carboxipeptidasa II/sangre; L-Lactato Deshidrogenasa/sangre; Recurrencia Local de Neoplasia/sangre; Recurrencia Local de Neoplasia/diagnóstico por imagen; Fosfopiruvato Hidratasa/sangre; Pronóstico; Prostatectomía/métodos; Neoplasias de la Próstata/sangre; Neoplasias de la Próstata/cirugía; Neoplasias de la Próstata/terapia; Estudios Retrospectivos

Palabras clave

Biochemical recurrence; Biomarker; PET; Salvage surgery

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fosfopiruvato Hidratasa / Neoplasias de la Próstata / Antígeno Carcinoembrionario / Biomarcadores de Tumor / Fosfatasa Alcalina / L-Lactato Deshidrogenasa / Recurrencia Local de Neoplasia Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: World J Urol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google